Sawicki P T
Klinik für Stoffwechselkrankheiten und Ernährung, Heinrich-Heine- Universität, Düsseldorf, Bundesrepublik Deutschland.
Wien Klin Wochenschr. 1995;107(21):629-39.
Patients with diabetes mellitus have a exaggerated risk for cardio- and cerebrovascular complications. Hypertension is very common in these patients. To date, betablockers and diuretics are the only antihypertensive agents for which a reduction of cardio- and cerebrovascular mortality and morbidity in patients with or without diabetes mellitus has been proven. Metabolic effects of these substances are clinically irrelevant or non existent. Proposed advantages of the newer antihypertensive agents, such as reduction of insulin resistance or a specific nephroprotective effect of ACE-inhibitors, has not been proven yet in a scientific way.
糖尿病患者发生心脑血管并发症的风险极高。高血压在这些患者中非常常见。迄今为止,β受体阻滞剂和利尿剂是仅有的已被证实可降低糖尿病患者或非糖尿病患者心脑血管死亡率和发病率的降压药物。这些药物的代谢作用在临床上无关紧要或不存在。新型降压药物所宣称的优势,如降低胰岛素抵抗或ACE抑制剂具有特定的肾脏保护作用,尚未得到科学证实。